Exelixis
EXEL
#1697
Rank
$9.95 B
Marketcap
$34.85
Share price
0.58%
Change (1 day)
66.51%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company